Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/688553 stock hub

SHA/688553 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/688553is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
8.5B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/688553
In the news

Latest news · SHA/688553

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E377.8
P25 23.5P50 41.3P75 83.2
ROE0.5
P25 -0.9P50 4.1P75 8.8
ROIC4.1
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/688553 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
217
Groups with data
11
Currency
CNY
Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
China
Country code
CN
Employees
1,331
Employees Change
-51%
Employees Change Percent
-3.69
Enterprise value
CNY 6.4B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE100004ZT4
Last refreshed
2026-05-10
Market cap
CNY 8.5B
Price
CNY 20.2
Price currency
CNY
Sector
Healthcare
Sic
2834
Symbol
sha/688553
Website
https://www.huiyupharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
0.26%
EV Earnings
285.37x
EV/EBIT
93.14x
EV/EBITDA
39.26x
EV/FCF
229.81x
EV/Sales
6.25x
FCF yield
0.33%
P/B ratio
2.26x
P/E ratio
377.8x
P/S ratio
8.28x
PE Ratio3 Y
76.05x
PE Ratio5 Y
60.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
6.71%
EBITDA Margin
15.78%
FCF margin
2.72%
Gross margin
78.56%
Gross Profit
CNY 807.8M
Gross Profit Growth
-11.32%
Gross Profit Growth Q
6.63%
Gross Profit Growth3 Y
-9.8%
Gross Profit Growth5 Y
-10.33%
Net Income
CNY 22.5M
Net Income Growth
-91.11%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
-48.83%
Net Income Growth5 Y
-43.88%
Pretax Margin
-0.45%
Profit Margin
2.19%
ROA
0.86
Roa5y
2.75
ROCE
1.79
ROE
0.46
Roe5y
7.72
ROIC
4.1
Roic5y
25.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
45.89%
Cagr3y
9.44%
EPS Growth
-90.99
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
-48.68
EPS Growth5 Y
-45.52
FCF Growth
-77.79%
FCF Growth5 Y
-35.12%
OCF Growth
-53.41%
OCF Growth Q
687.17%
OCF Growth3 Y
38.61%
OCF Growth5 Y
-25.47%
Revenue Growth
-5.73x
Revenue Growth Q
12.61x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
-6.66x
Revenue Growth5 Y
-7.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CNY 0.2
Assets
CNY 5.1B
Cash
CNY 2.8B
Current Assets
CNY 3.3B
Current Liabilities
CNY 1.3B
Debt
CNY 690.6M
Debt EBITDA
CNY 4.22
Debt Equity
CNY 0.18
Debt FCF
CNY 24.68
Equity
CNY 3.8B
Liabilities
CNY 1.4B
Long Term Assets
CNY 1.8B
Long Term Liabilities
CNY 94.5M
Net Cash
CNY 2.1B
Net Cash By Market Cap
CNY 24.33
Net Cash Growth
-11.21%
Net Debt EBITDA
CNY -12.77
Net Debt Equity
CNY -0.55
Net Debt FCF
CNY -74.03
Tangible Book Value
CNY 3.7B
Tangible Book Value Per Share
CNY 8.51
WACC
6.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.61
Inventory Turnover
0.91
Net Working Capital
CNY -36.3M
Quick ratio
2.25
Working Capital
CNY 2B
Working Capital Turnover
CNY 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
1.23%
Dividend Growth
117.46%
Dividend Growth Years
1%
Dividend per share
CNY 0.46
Dividend Years
4
Dividend Yield
2.29%
Ex Div Date
2025-06-13
Last Dividend
CNY 0.46
Payout Frequency
Annual
Payout Ratio
860.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
45.86%
200-day SMA
20.68
3Y total return
31.09%
50-day SMA
18.97
50-day SMA vs 200-day SMA
50under200
All Time High
42.59
All Time High Change
-52.57%
All Time High Date
2021-10-26
All Time Low
9.45
All Time Low Change
113.76%
All Time Low Date
2024-02-06
ATR
1.02
Beta
0.58
Beta1y
-0.17
Beta2y
0.06
Ch YTD
13.55
High
20.3
High52
28.28
High52 Date
2025-08-26
High52ch
-28.57%
Low
19.98
Low52
13.48
Low52 Date
2025-05-19
Low52ch
49.85%
Ma50ch
6.51%
Price vs 200-day SMA
-2.32%
RSI
54.4
RSI Monthly
53.64
RSI Weekly
51.81
Sharpe ratio
0.67x
Sortino ratio
1.26
Total Return
3.53%
Tr YTD
13.55
Tr1m
-17.75%
Tr1w
-0.69%
Tr3m
4.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 69M
Operating Income Growth
-27.63
Operating Income Growth Q
32.38
Operating Income Growth3 Y
20.53
Operating Income Growth5 Y
-30.8
Operating margin
6.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
212,522,378%
Net Borrowing
319,946,000
Shares Insiders
42.2%
Shares Institutions
9.34%
Shares Out
421,460,122
Shares Qo Q
11.02%
Shares Yo Y
-1.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
CNY 28M
Average Volume
14,322,288.05x
Bv Per Share
8.64
CAPEX
CNY -80.1M
Ch1m
-17.75
Ch1w
-0.69
Ch1y
42.05
Ch3m
4.94
Ch3y
23.85
Ch6m
-2.74
Change
0.25%
Change From Open
-0.49
Close
20.15
Days Gap
0.74
Depreciation Amortization
93,182,619
Dollar Volume
88,620,450.2
Earnings Date
2026-04-25
EBIT
CNY 69M
EBITDA
CNY 162.2M
EPS
CNY 0.05
F Score
4
FCF
CNY 28M
FCF EV Yield
0.44x
FCF Per Share
CNY 0.07
Financing CF
242,259,675
Fiscal Year End
December
Founded
2,010
Graham Number
3.23568
Graham Upside
-83.98
Income Tax
CNY -22.5M
Investing CF
273,131,544
Is Primary Listing
1
Last Earnings Date
2026-04-25
Last Report Date
2026-03-31
Lynch Fair Value
CNY 0.27
Lynch Upside
-98.67
Ma150
19.93
Ma150ch
1.35%
Ma20
20.06
Ma20ch
0.72%
Net CF
620,964,898
Next Earnings Date
2026-08-28
Open
20.3
P FCF Ratio
304.2
P OCF Ratio
78.74
Payment Date
2025-06-13
Position In Range
68.75
Ppne
1,458,587,248
Price Date
2026-05-08
Price EBITDA
CNY 52.48
Ptbv Ratio
2.29
Relative Volume
0.31x
Revenue
1,028,299,009x
Tax By Revenue
-2.19x
Tr6m
-2.74%
Volume
4,387,151
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/688553 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.3%
$0.46 annual per share
Payout ratio
+860.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
+3.5%
Next ex-dividend date: 2025-06-13
Performance

SHA/688553 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+45.9%
S&P 500 1Y: n/a
3Y total return
+31.1%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHA/688553?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.3%
Share of float held by funds and institutions
Insider ownership
+42.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.2%
Negative means the company is buying back shares.
Technical

SHA/688553 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
54.4
Neutral momentum band
Price vs 200-day MA
-2.3%
50/200-day relationship not available
Beta (5Y)
0.58
Less volatile than the market
Sharpe ratio
0.67
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/688553

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688553 stock rating?

sha/688553 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688553 analysis?

The full report lives at /stocks/sha/688553/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688553?

The latest report frames sha/688553 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688553 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sha/688553 stock profile: metrics, valuation and analysis | Agent IA du Marché Boursier